Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
fibrosarcoma
MeSH D005354 - fibrosarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012509:
Sarcoma
23 Companies
8 Drugs
$
Success rate
D018218:
Fibrous tissue neoplasms
0 Companies
0 Drugs
Success rate
D005354:
Fibrosarcoma
6 Companies
1 Drug
$
Success rate
D018223:
Dermatofibrosarcoma
19 Companies
1 Drug
$
Success rate
D018319:
Neurofibrosarcoma
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
75
%
3/4
Phase 2
23
%
3/13
Phase 3
25
%
1/4
Approved:
1
Overall Success rate:
4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
Dacarbazine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use